U.S. Stem Cell, Inc.

CIK 1388319 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for U.S. Stem Cell, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2023NT 10-Q0001185185-23-000510
Apr 14, 202310-K0001185185-23-000339
Mar 31, 2023NT 10-K0001185185-23-000280
Nov 9, 202210-Q0001185185-22-001257
Aug 22, 202210-Q0001185185-22-000980
Aug 15, 2022NT 10-Q0001185185-22-000919
Jul 8, 202210-K/A0001185185-22-000809
May 23, 202210-Q0001185185-22-000682
May 16, 2022NT 10-Q0001185185-22-000640
Apr 29, 202240001185185-22-000518
Mar 31, 202210-K0001185185-22-000363
Mar 25, 202240001185185-22-000329
Mar 9, 20228-K/A0001185185-22-000260
Mar 9, 20228-K0001185185-22-000256
Mar 4, 202240001185185-22-000249
Nov 9, 202110-Q0001185185-21-001622
Sep 13, 2021253G20001185185-21-001276
Sep 10, 2021QUALIF9999999994-21-000283
Aug 30, 20211-A0001185185-21-001210
Aug 12, 202110-Q0001185185-21-001108
Jul 23, 202140001185185-21-001026
Jul 23, 202140001185185-21-001028
Jul 16, 202110-Q0001185185-21-000991
Jul 16, 202110-Q0001185185-21-000989
Jul 16, 202110-Q0001185185-21-000988